Nutraceuticals is the use of vitamins and nutritious products to improve human health. The nutraceutical business is developing active ingredients for the following market segments:

• Dietary Supplements - e.g. vitamin capsules & tablets;
• Personal Care - e.g. skin care products; and
• Functional Foods and Beverages - e.g. nutritionally enhanced foods.

Phosphagenics’ nutraceutical business is a revenue-generating growth business.

The first commercial product is Phospha E^®, a novel patented derivative of vitamin E, and is available as:  

• A Personal Care ingredient (Vital ET™) – globally

Phosphagenics is collaborating with Nestlé Nutrition to develop Phospha E^® for use in nutritional products that target the prevention and treatment of metabolic syndrome.

Metabolic syndrome is characterised by a group of metabolic risk factors – abdominal obesity and elevated blood pressure, cholesterol, triglycerides and blood glucose. The root causes of metabolic syndrome are overweight/obesity, physical inactivity, and genetic factors. 
 

Nutraceutical Product Portfolio 

The route to market for Phosphagenics’ nutraceutical products is through partnering with companies that have established distribution networks within the relevant market segments. Phosphagenics does not intend to become a direct marketer of products to consumers, and aims to manufacture and supply the active ingredients to its partners or distributors where commercially feasible.